Bionomics Limited logo

Bionomics Limited

NASDAQ:BNOX

Overview | Financials
Company Name Bionomics Limited
Symbol BNOX
Currency USD
Price 0.595
Market Cap 7,110,820
Dividend Yield 0%
52-week-range 0.5 - 6.41
Industry Biotechnology
Sector Healthcare
CEO Dr. Spyridon Papapetropoulos M.D., Ph.D.
Website https://www.bionomics.com.au

An error occurred while fetching data.

About Bionomics Limited

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2

Related Stocks

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

SCYX

1.27 USD

Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

BOLT

0.648 USD

Qilian International Holding Group Limited logo

Qilian International Holding Group Limited

QLI

5.41 USD

Novo Integrated Sciences, Inc. logo

Novo Integrated Sciences, Inc.

NVOS

0.285 USD

InflaRx N.V. logo

InflaRx N.V.

IFRX

1.52 USD

DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc.

DMAC

4.03 USD

Financials

Numbers are in millions USD

Numbers are in millions USD